Elmquist WF - Search Results

1

Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.

Agarwal S, Sane R, Oberoi R, Ohlfest JR, Elmquist WF. Agarwal S, et al. Among authors: elmquist wf. Expert Rev Mol Med. 2011 May 13;13:e17. doi: 10.1017/S1462399411001888. Expert Rev Mol Med. 2011. PMID: 21676290 Free PMC article. Review.

2

Distribution of STI-571 to the brain is limited by P-glycoprotein-mediated efflux.

Dai H, Marbach P, Lemaire M, Hayes M, Elmquist WF. Dai H, et al. Among authors: elmquist wf. J Pharmacol Exp Ther. 2003 Mar;304(3):1085-92. doi: 10.1124/jpet.102.045260. J Pharmacol Exp Ther. 2003. PMID: 12604685

3

Interactions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors.

Shaik N, Pan G, Elmquist WF. Shaik N, et al. Among authors: elmquist wf. J Pharm Sci. 2008 Dec;97(12):5421-33. doi: 10.1002/jps.21372. J Pharm Sci. 2008. PMID: 18393290 Free PMC article.

4

Substrate-dependent breast cancer resistance protein (Bcrp1/Abcg2)-mediated interactions: consideration of multiple binding sites in in vitro assay design.

Giri N, Agarwal S, Shaik N, Pan G, Chen Y, Elmquist WF. Giri N, et al. Among authors: elmquist wf. Drug Metab Dispos. 2009 Mar;37(3):560-70. doi: 10.1124/dmd.108.022046. Epub 2008 Dec 4. Drug Metab Dispos. 2009. PMID: 19056916 Free PMC article.

5

P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib.

Chen Y, Agarwal S, Shaik NM, Chen C, Yang Z, Elmquist WF. Chen Y, et al. Among authors: elmquist wf. J Pharmacol Exp Ther. 2009 Sep;330(3):956-63. doi: 10.1124/jpet.109.154781. Epub 2009 Jun 2. J Pharmacol Exp Ther. 2009. PMID: 19491323

6

Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux.

Agarwal S, Sane R, Gallardo JL, Ohlfest JR, Elmquist WF. Agarwal S, et al. Among authors: elmquist wf. J Pharmacol Exp Ther. 2010 Jul;334(1):147-55. doi: 10.1124/jpet.110.167601. Epub 2010 Apr 26. J Pharmacol Exp Ther. 2010. PMID: 20421331 Free PMC article.

7

The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain.

Agarwal S, Sane R, Ohlfest JR, Elmquist WF. Agarwal S, et al. Among authors: elmquist wf. J Pharmacol Exp Ther. 2011 Jan;336(1):223-33. doi: 10.1124/jpet.110.175034. Epub 2010 Oct 15. J Pharmacol Exp Ther. 2011. PMID: 20952483 Free PMC article.

8

Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up.

Agarwal S, Hartz AM, Elmquist WF, Bauer B. Agarwal S, et al. Among authors: elmquist wf. Curr Pharm Des. 2011;17(26):2793-802. doi: 10.2174/138161211797440186. Curr Pharm Des. 2011. PMID: 21827403 Free PMC article. Review.

9

Determination of cediranib in mouse plasma and brain tissue using high-performance liquid chromatography-mass spectrometry.

Wang T, Oberoi RK, Elmquist WF. Wang T, et al. Among authors: elmquist wf. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Dec 15;879(32):3812-7. doi: 10.1016/j.jchromb.2011.10.025. Epub 2011 Oct 29. J Chromatogr B Analyt Technol Biomed Life Sci. 2011. PMID: 22127272 Free PMC article.

10

Brain distribution of cediranib is limited by active efflux at the blood-brain barrier.

Wang T, Agarwal S, Elmquist WF. Wang T, et al. Among authors: elmquist wf. J Pharmacol Exp Ther. 2012 May;341(2):386-95. doi: 10.1124/jpet.111.190488. Epub 2012 Feb 8. J Pharmacol Exp Ther. 2012. PMID: 22323823 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters